It is worth repeating that Navarra has a privileged ecosystem in terms of biotechnology in general and biomedicine in particular. The existence of three universities, several technology centers, and an environment with consolidated companies that are committed to diversify in biotechnology, less consolidated but equally innovative companies, entrepreneurs, etc... as well as a powerful public-private health system, make Navarre an exceptional enclave.

But also, in the case of Navarra, the existence of these agents acquires a added value through the complementarity and growing partnership among them. Also the coordination of all the agents, recently enhanced in a special way through Aditech, acts as a multiplier of the potential of each agent separately.

There are clear examples such as the high school de research Sanitaria de Navarra, (IdiSNA) which has brought together hospitals and other health resources, research centers, and public and private universities to promote biomedical research , or the launch by the Government of Navarra of "tractor projects" in which one or more centers are consortiated with business entities in order, as the call itself states, "to guide this research of the Centers towards lines with high industrial potential and market access".

I believe that this must be the way for Navarre, being a small community, to continue advancing along the path of excellence and competitiveness compared to other regions with more economic, territorial, demographic, etc. power. Without forgetting the support of public institutions that provide adequate resources and develop appropriate policies that contribute to this. Let us hope that this is the case of the next Science and Technology Law of Navarra.

It will be important that each entity maintains its own identity and, as far as possible, that there is a level of specialization that allows the whole to be more efficient and avoids redundancies of resources.

Each entity or each agent occupies a space in the biomedicine value chain, from the most basic research to the industry, always having as goal, as it cannot be otherwise the patients and society in general.

In this sense, it is important to further deepen the partnership between all entities and that this partnership be a back and forth or, better yet, a partnership of network, not a linear one, given the complexity of new therapies. That the science of a research center can be transferred to the industry so that it finally reaches the patient is the desired goal . But along the way, learning must be generated among all participants, new ideas must be developed -some of them risky or disruptive- that in turn give rise to new products or make existing ones better or more accessible.

The partnership, or rather, the work , between the generators of knowledge, those who develop it, those who generate new products and bring them to the market for user adoption, is fundamental. For all these reasons, the joint work between research or technology centers, universities and industry is essential. That is the challenge and I believe that Navarra is capable of it.

Perhaps this is a simplistic, naïve or overly optimistic approach. I know that day-to-day things in the "trenches" of laboratories, production plants or offices are full of problems and obstacles. But in order to overcome them, you have to believe that it is worth it and that you can do it.